Johnson et al used the Albumin-Bilirubin (ALBI) grade to evaluate hepatic function and overall survival for patients with hepatocellular carcinoma. The authors are from multiple institutions in England, the United States, China, Spain and Japan.
Patient selection: hepatocellular carcinoma
Parameters:
(1) serum albumin in g/L
(2) serum total bilirubin in µmol/L
linear predictor =
= (0.66 * LOG10(bilirubin)) - (0.085 * (albumin))
Linear Predictor
Grade
<= -2.6
Grade 1
-1.39 to -2.59
Grade 2
> -1.39
Grade 3
Grade
Median Survival
1 Year Survival
1
12.7 months
100%
2
7.2 months
82%
3
3.6 months
63%
To read more or access our algorithms and calculators, please log in or register.
